American Cancer Society BrightEdge Annual Report Reveals Impact of $43 Million Deployed to Advance Innovation and Healthcare Access
Oct 28, 2024 – ACS Impact Venture Fund (AIVF)’s active portfolio of 16 companies is transforming the fight against cancer through impact investing BOSTON, Oct. 28, 2024 – BrightEdge LLC, the American Cancer Society’s (ACS) venture capital and impact investment arm, has published its most recent annual report highlighting progress in the fight to end cancer as we know it. Since inception through EOY 2023, BrightEdge has invested … Continue reading American Cancer Society BrightEdge Annual Report Reveals Impact of $43 Million Deployed to Advance Innovation and Healthcare Access